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ABSTRACT 
Background: Repeated administration of anxiety sensitivity measures can often 
produce declining scores, even in ostensible control groups, which is a significant 
concern for researchers. The reasons for these changes are as yet unknown, but 
could be because of regression to the mean in samples selected on extreme scores, 
exposure to general information about anxiety contained in psychiatric 
interviews, or mere exposure to anxiety sensitivity information. Methods: This 
study sought to experimentally evaluate these potential explanations using a 
comprehensive measure of anxiety sensitivity and its subcomponents, a non-anxiety 
sensitivity measure (self-esteem), and participants representing the full 
spectrum of anxiety sensitivity. Results: Results indicated significant decreases 
in anxiety sensitivity scores (but not self-esteem scores) that could not be 
accounted for by regression to the mean or exposure to information about 
anxiety in general. Conclusions: Several potential explanations for these 
findings are reviewed and implications for research study designs are discussed. 
  
INTRODUCTION 
Anxiety sensitivity is the persistent fear of anxietyrelated 
symptoms arising from beliefs that such 
symptoms are associated with negative physical, social, 
or psychological consequences.[1] Anxiety sensitive 
individuals have a tendency to catastrophize relatively 
benign anxiety-related physiological sensations,[1] such 
as believing that heart palpitations are a sign of an 
imminent heart attack. Over the past 20 years, 
considerable research has accumulated demonstrating 
that anxiety sensitivity plays an important role in the 
development and maintenance of various forms of 
psychopathology, particularly anxiety and panic 
[e.g.,].[2,3] 
 
Anxiety sensitivity was initially conceptualized as a 
dispositional construct, denoting a consistent tendency 
to respond fearfully when anxiety-related symptoms are 
present.[1] Early research into the psychometric properties 
of the Anxiety Sensitivity Index [ASI],[4] which has 
been the predominant measure of anxiety sensitivity, 
indicated that scores on the measure tend to predict 
later scores, with a test–retest correlation of 0.71 across 
a 3-year interval.[2] Subsequent studies have shown 
test–retest correlations of similar magnitude in both 
adult and adolescent samples assessed over varying 
intervals, ranging from 2 weeks to 4 years [e.g.,].[5,6] 
Although high test–retest correlations provide some 
support for the ‘‘stability’’ of scores on the measure, 
and given sufficient temporal distance between testing 
administrations can be interpreted to mean that a 
construct is dispositional in nature, test–retest correla- 
tions provide, in part, an estimate of the degree to 
which the relative position of scores stays the same 
across time. Recall that adding or subtracting a 
constant from every score on the second administration 
of a measure will not affect the magnitude of the 
correlation coefficient. Hence, it is possible to have 
significant mean differences in scores across administrations, 
whereas at the same time having high 
test–retest correlations. Recently, anxiety sensitivity 
researchers have begun to note exactly such a 
phenomenon. 
 
In an attempt to examine the stability of anxiety 
sensitivity scores,[5] administered the ASI to a large 
sample of adolescents yearly across a 4-year period. 
Although results indicated significant ASI test–retest 
correlations across the 4 years, overall mean ASI scores 
declined at each assessment. Cluster analyses were 
conducted to examine the patterns of ASI scores over 
time, and more than 80% of participants were classified 
as having ‘‘stable low’’ or ‘‘stable high’’ anxiety 
sensitivity. However, further examination of the ‘‘stable 
low’’ and ‘‘stable high’’ groups revealed decreases in ASI 
scores of greater than 0.5 and 1.0 SD for the two groups, 
respectively, over the 4-year period. Thus, despite the 
high test–retest reliability of anxiety sensitivity scores, 
participants were reporting significantly less fear of 
anxiety symptoms at each assessment session. 
Several recent empirical studies of panic prevention 
or treatment programs have also noted significant 
reductions in anxiety sensitivity scores among individuals 
assigned to ostensible control conditions. In one 
study,[7] attempted to evaluate the efficacy of a panic 
prevention program in individuals who had been 
identified as at risk for panic disorder (i.e., experienced 
at least one panic attack in the past year and had ASI 
scores 415). Participants were randomly assigned to 
either 6 months of cognitive-behavioral treatment, 
which included psychoeducation and interoceptive 
exposure, or to a wait-list control condition. All 
participants were administered a diagnostic assessment 
before beginning their respective treatment protocols. 
Results indicated that there were no ASI differences 
between the treatment and control groups, and both 
groups showed about a 1 SD decline in ASI scores at 
posttesting. The authors attributed ASI score reductions 
in the wait-list control condition to non-specific 
factors, such as reassurance, support, or the expectation 
of receiving treatment. However, because participants 
were pre-selected based on extreme scores, regression 
to the mean could not be ruled out as a plausible 
alternative explanation. 
 
Schmidt et al. [2007][8] noted similar issues in a 
recent attempt to evaluate a longitudinal prevention 
program for individuals at risk for anxiety and other 
axis I disorders. Participants with high ASI scores 
(41.5 SD above the mean) who did not meet current 
criteria for an axis I disorder (as assessed by a 
structured diagnostic interview) were randomized to 
either Anxiety Sensitivity Amelioration Training 
(ASAT) or control. Participants in the ASAT group 
watched a video presentation that provided psychoeducation 
regarding anxiety, stress, and anxiety sensitivity 
as well as behavioral exercises designed to correct 
maladaptive interoceptive conditioning. The control 
condition received general health and nutrition information 
via a computer presentation of comparable 
length to the ASAT presentation. Although results 
indicated that the ASAT group reported greater 
decreases in ASI scores immediately after the presentations, 
the control condition also reported declines in 
anxiety sensitivity (approximately 0.5 SD), and the 
group differences were not maintained at 1 and 2-year 
follow-ups. 
 
On the basis of the observation that structured 
diagnostic interviews are frequently administered to 
experimental and control participants in anxiety sensitivity 
intervention studies,[9] suggested that reductions in 
anxiety sensitivity may occur in response to the 
diagnostic interviews. Specifically, anxiety disorder 
interviews may provide indirect normalizing information 
regarding common anxiety-related physical symptoms 
via the assessment of panic attack criteria, which 
may, in turn, lead individuals with high anxiety 
sensitivity to reevaluate their catastrophic beliefs about 
the consequences of such symptoms. To test this 
hypothesis,[9] used a non-experimental design to compare 
two separate ‘‘cohorts’’ of high anxiety sensitivity 
individuals (ASI scores 423) with respect to changes in 
anxiety sensitivity scores over a 2-week period. One 
cohort received a diagnostic interview (Structured 
Clinical Interview for DSM-IV—SCID-IV) as a function 
of participation, whereas the second one did not. 
Results indicated that the cohort exposed to a structured 
interview reported a significant decline in anxiety 
sensitivity scores at a 2-week follow-up assessment, but 
the cohort that did not receive a structured interview 
exhibited no change in anxiety sensitivity scores. A 
significant limitation of this study, however, was that the 
research design involved ex post facto analyses of two 
cohort samples that were derived from separate studies 
with seemingly different initial aims (one cohort was 
derived from a treatment outcome study) and somewhat 
different inclusion criteria directly relevant to anxiety 
sensitivity. Both cohorts were also pre-selected based on 
elevated anxiety sensitivity scores, which provide a 
limited picture of anxiety sensitivity fluctuations and 
the ability to isolate potential regression to the mean 
effects. Moreover, the psychiatric interview included 
exposure to both anxiety-related and non-anxiety–related 
symptoms. Thus, it is not clear whether exposure 
to anxiety information per se was responsible for the 
decline in scores observed. Finally, because data from 
the cohorts were presumably collected at different time 
points, one cannot rule out the possibility that the 
changes in anxiety sensitivity observed in the first 
cohort, or lack of changes in the second, are not better 
 
accounted for by exposure to extraneous variables 
associated with their different histories. 
The phenomenon of declining anxiety sensitivity 
scores raises important questions concerning the 
conceptualization and stability of anxiety sensitivity, 
as well as the potential clinical utility of administering 
diagnostic interviews to patients. This study is, to the 
best of our knowledge, the first to experimentally 
examine the effects of repeated instrument administration 
of anxiety sensitivity measures on anxiety sensitivity 
scores. In contrast to earlier studies, participants 
in this study were not pre-selected based on extreme 
anxiety sensitivity scores. Also, to build on previous 
research, an expanded measure of anxiety sensitivity 
that also allowed for an assessment of changes in the 
subcomponents of anxiety sensitivity was used and 
compared to a non-anxiety sensitivity measure. An 
analysis of subcomponent changes may aid in discriminating 
the specific aspects of anxiety sensitivity that 
are affected by repeated administrations of anxiety 
sensitivity measures. Also, recall that researchers have 
speculated that exposure to general information about 
anxiety in the context of a structured diagnostic 
interview may be responsible for declines in anxiety 
sensitivity scores. To examine this possibility, the 
effects of administering an anxiety-related structured 
interview were compared with administration of a nonanxiety– 
related structured interview and no interview. 
In addition, we compared the effects of providing 
general information about anxiety indirectly via interview 
to direct provision of information about anxietyrelated 
symptoms via interview plus education. Finally, 
in contrast to previous studies,[7,9] we also assessed 
anxiety sensitivity immediately after the administration 
of the respective manipulations, and not just at a 2- 
week follow-up, to establish a closer temporal link 
between the variables of interest and changes in anxiety 
sensitivity scores. Following the logic of,[9] exposure to 
a structured interview specific to anxiety disorders 
should produce greater declines in anxiety sensitivity 
scores compared to a non-anxiety–related interview 
and control condition. Furthermore, if the declines in 
anxiety sensitivity scores noted in previous reports are 
truly the result of participants receiving indirect 
normalizing information from anxiety-related diagnostic 
interviews, the direct provision of anxiety-related 
information in combination with an anxiety disorders 
diagnostic interview should provide even greater 
reductions in anxiety sensitivity scores. 
 
METHODS 
 
PARTICIPANTS 
 
The participants were 190 undergraduate students, ages 18 
through 35 years (M519.36, SD52.02) who received course credit 
for their participation. The majority of participants were women 
(61.6%) and Caucasian (92%). Of the 190 participants who began the 
study, 20 failed to return to the laboratory to complete follow-up 
measures. Thus, the analyses that follow are based on the 170 
completers, unless otherwise stated. The consent process and 
protocol were reviewed by the Institutional Review Board 
for the Protection of Human Subjects at the Appalachian State 
University. 
 
 
 
INSTRUMENTS 
 
Anxiety Sensitivity Index-Revised. The ASI-Revised[10] is 
a self-report questionnaire that assesses fear of anxiety and anxietyrelated 
sensations. The revised version of the ASI consists of 36 items 
(as opposed to 16 on the original ASI) that are rated on a 5-point 
Likert scale, ranging from ‘‘Very Little’’ to ‘‘Very Much.’’ The ASI-R 
was designed to assess the major subcomponents of anxiety sensitivity 
in greater depth. The ASI-R has been shown to assess a higher-order 
general anxiety sensitivity factor, and four lower-order factors, which 
were labeled: (1) fear of respiratory symptoms, (2) fear of publicly 
observable anxiety reactions, (3) fear of cardiovascular symptoms, and 
(4) fear of cognitive dyscontrol.[10] Construct validity for the ASI-R 
has been established based on significant correlations with the 
original version of the ASI [r50.94].[10] The ASI-R has demonstrated 
excellent internal consistency (a50.95), with all 36 items 
showing adequate item–total correlations [M50.58, 
range50.40–0.71].[11] The ASI-R was selected for use in this study 
based on its well-documented psychometric properties and its ability 
to comprehensively assess the full spectrum of the anxiety sensitivity 
construct. 
 
Rosenberg Self-Esteem Scale. The Rosenberg Self-esteem 
Scale [RSES][12] is a 10-item, self-report scale, designed to 
measure global self-esteem. Anxiety sensitivity and self-esteem have 
been shown to be negatively correlated[13] and both phenomena are 
conceptualized as relatively stable dispositional characteristics. 
Thus, the RSES was included in this study in an attempt to rule 
out general test reactivity as an explanation for the decline in 
anxiety sensitivity scores. The RSES consists of 10 items that are 
rated on a 4-point Likert scale, ranging from ‘‘Strongly Agree’’ to 
‘‘Strongly Disagree.’’ The RSES has demonstrated good reliability 
and validity across a large number of different sample 
groups [e.g.,].[14] Specifically, Cronbach a´ scores have ranged between 
0.77 and 0.88, and test–retest correlations have ranged between 
0.82 and 0.85 across 1 and 2-week intervals, respectively [for further 
details, see].[15,16] 
 
 
 
Structured Clinical Interview for DSM-IV Axis I 
Disorders. The SCID-IV Axis I Disorders [SCID-I][17] is a 
semi-structured interview designed to assist trained raters in making 
reliable axis I diagnoses. In this study, only the anxiety disorders 
(SCID-A) and psychotic disorders modules (SCID-P) were used. The 
anxiety disorders module assesses for the following anxiety disorders: 
panic disorder, agoraphobia, specific phobias, social phobia, posttraumatic 
stress disorder, obsessive-compulsive disorder, and generalized 
anxiety disorder. The SCID-A has demonstrated good reliability, 
with k’s ranging between 0.57 (for obsessive-compulsive disorder) 
and 0.88 [for posttraumatic stress disorder; e.g.,],[18] and validity. The 
SCID-P assesses for schizophrenia, schizophreniform, schizoaffective 
disorder, delusional disorder, brief psychotic disorder, and psychotic 
disorder that are not otherwise specified. The reliability and validity 
of the SCID-P have also been well documented, with the SCID-P 
leading to accurate psychotic disorder diagnoses and k estimates as 
high as 0.94.[19] 
 
 
 
PROCEDURE 
 
Participants completed the informed consent process and were 
randomly assigned to one of four conditions: (1) SCID-IV Anxiety 
Disorders Module (SCID-A), (2) SCID-A plus educational information 
concerning common physiological responses to stress, (3) a nonanxiety– 
related structured interview (SCID-Psychotic Disorders 
Module—SCID-P), or (4) no interview/no information. Regardless 
of group assignment, all participants completed the ASI-R and RSES 
at two time points: (1) before completing the tasks associated with the 
respective experimental conditions and (2) at a 2-week follow-up 
appointment. The order of completion for the questionnaires was 
counterbalanced across participants. All participants also completed 
the ASI-R one additional time immediately after the experimental 
manipulation (e.g., completing the interview). Individuals assigned to 
the no interview/no information control condition were asked to wait 
in an empty research room for approximately 5 min before 
completing the ASI-R the second time. The purpose of the 5-min 
wait period was to provide the control condition with a comparable 
time frame between baseline and post-ASI–R measurements to those 
groups that were administered the SCID-A and SCID-P. Furthermore, 
one of the reasons for selecting the SCID-P as the nonanxiety– 
related interview was that it is comparable to the SCID-A in 
average administration time (approximately 4–7 min depending on 
participant responses). 
Participants assigned to one of the conditions receiving the SCIDA 
or SCID-P were administered their respective SCID modules by a 
research assistant who had received advanced training in the 
administration of the SCID. The training protocol for the 
interviewers included a review of SCID materials, SCID administration 
observations of an experienced clinician, and satisfactory practice 
administrations to volunteers before working with research participants. 
The research assistant was not aware of participant scores on 
the self-report measures before SCID administration. In addition to 
completing the interview, participants in the SCID-A plus information 
group were provided with details about the physiology of anxiety 
and panic reactions via an electronic voice recording. The information 
they received was based on a slightly modified version of the 
psychoeducation information contained in the Mastery of Your 
Anxiety and Panic treatment manual[20] directly explaining the 
fight–flight response, the typical psychophysiological symptoms of 
a fear/panic response, and reasons why it is beneficial and adaptive for 
the organism to respond to danger in this manner. 
 
 
 
RESULTS 
 
The study hypotheses were tested using separate 
group by assessment session mixed-model analyses of 
variance (ANOVAs) for each of the dependent measures. 
The repeated measures factor for the ASI-R 
analyses had three levels (baseline, post, and followup), 
whereas RSE measurements were only taken at 
baseline and follow-up. 
 
 
 
COMPLETERS VERSUS NON-COMPLETERS 
 
Participants who completed the entire protocol (i.e., 
had baseline, post, and follow-up measurements) were 
compared with those who dropped out of the study to 
determine whether dropouts differed from completers 
in any meaningful way. On average, participants who 
failed to complete the study were more likely to be 
male, t(188)5_2.62, P5.01 and had lower levels of 
baseline anxiety sensitivity (M524.75 compared to 
completers M535.08), t(188)5_2.26, P5.03. All 
dropouts occurred between post and follow-up measurements. 
Thus, group differences in ASI-R change 
from baseline to post were examined to determine 
whether non-completers were reporting significantly 
different changes in ASI-R scores. Results indicated 
that completers and non-completers did not significantly 
differ on ASI-R score change from baseline to 
post, t(188)5_1.18, P5.24. Thus, although noncompleters 
reported lower anxiety sensitivity scores at 
baseline, they were reporting comparable decreases in 
anxiety sensitivity from baseline to post as those 
individuals who completed the entire study. 
 
 
 
BASELINE ANALYSES 
 
One-way ANOVAs and w2 analyses indicated that the 
groups were comparable at baseline on all demographic 
variables (all P4.10; see Table 1). In addition, no 
significant differences were noted between the groups 
on baseline levels of anxiety sensitivity (ASI-R, 
F(3, 169)51.60, P4.10). Baseline ASI-R scores 
(M535.1, SD519.7) were comparable to those of 
non-selected samples in previous reports [e.g., 
M525.7, SD519.6],[11] and substantially lower than 
ASI-R scores in clinical samples [e.g., M555.6, 
SD530.0].[21] 
 
 
 
 
 
 
 
TEST–RETEST CORRELATIONS 
 
Baseline scores on the outcome measures were 
correlated with their corresponding follow-up scores 
(and also at post for the ASI-R). Results indicated 
moderate to high test–retest correlations over a 2-week 
period for both of the outcome measures. Specifically, 
the ASI-R demonstrated the highest test–retest correlations, 
with baseline to post (r50.89), baseline to 
follow-up (r50.83), and post to follow-up (r50.91). 
RSES test–retest correlations (r50.84) were similar to 
those of the ASI-R. 
 
 
 
 
 
 
CHANGES IN OUTCOME MEASURES 
 
The primary purpose of this study was to examine 
changes in anxiety sensitivity scores under various 
conditions. Consequently, the effect of various assessment 
conditions on anxiety sensitivity, as measured by 
the ASI-R, was of principal interest. In addition, a 
measure of self-esteem (the RSES) was included in this 
study to determine whether any changes in scores 
found for the ASI-R would be specific to the construct 
of anxiety sensitivity, or whether general test reactivity 
could explain the findings. 
 
 
 
ANXIETY SENSITIVITY INDEX-REVISED 
 
Baseline, post, and follow-up means and standard 
deviations for the ASI-R are presented in Table 2. A 
4(group)_3(assessment session) repeated measures 
ANOVA was computed to determine whether ASI-R 
scores varied over time as a function of group. Results 
indicated a significant main effect for the assessment 
session, F(2, 332)553.04, Po.001, Zp 
250.24, with higher ASI-R scores at baseline (M535.08, 
SD519.66) than at post (M528.58, SD519.99) and 
follow-up (M527.84, SD520.95). Post hoc analyses 
indicated that the decrease from baseline to post was 
significant, as was the decrease from baseline to followup. 
However, the decrease from post to follow-up did 
not reach significance. No main or interaction effect 
for group was noted (P4.10). Thus, all four groups 
demonstrated comparable decreases in anxiety sensitivity 
scores. 
 
 
 
 
 
Although no significant differences were noted 
between the groups on ASI-R scores at baseline, mean 
differences between the groups at baseline ranged from 
0.33 to 7.38 points. Thus, to ensure that the lack of 
statistical differences noted between groups on the 
repeated measures ANOVA was not simply because of 
differing baseline ASI-R levels, the relative change in 
ASI-R scores was also compared across the groups. 
However, results indicated that the groups did not 
significantly differ with regard to the relative change in 
ASI-R scores from baseline to post, F(3, 169)52.31, 
P4.05 or from post to follow-up, F(3, 169)51.34, 
P4.05. 
 
 
 
HIGH VERSUS LOW ANXIETY SENSITIVITY 
COMPARISONS 
 
To examine whether the changes in ASI-R scores 
could be attributed to regression to the mean, separate 
repeated measures ANOVAs were conducted on 
individuals with high (41 SD above the mean) versus 
low (41 SD below the mean) ASI-R scores. Refer to 
Table 3 for ASI-R means and standard deviations for 
the high and low anxiety sensitivity groups at baseline, 
post, and follow-up. Results indicated significant 
reductions in ASI-R scores for both high (n527), 
F(2, 52)57.90, P5.001, Zp 2 50.23, and low anxiety 
sensitivity (n526), F(2, 50)511.06, Po.001, 
Zp 2 50.31, groups. A comparison of the relative change 
in ASI-R scores indicated that individuals with low 
anxiety sensitivity reported a 32% reduction in scores 
from baseline to post and a 31% decrease from baseline 
to follow-up. In contrast, individuals with high anxiety 
sensitivity only reported a 13 and 16% decrease in 
scores from baseline to post and baseline to follow-up, 
respectively. Thus, reductions in anxiety sensitivity 
scores appear to occur across the spectrum of anxiety 
sensitivity, thereby providing evidence against regression 
to the mean as a potential explanation for the 
decrease in anxiety sensitivity scores. 
 
 
 
ASI-R SUBSCALES 
 
On the basis of the significant findings with ASI total 
scores, analyses of the ASI subcomponents were also 
undertaken in an attempt to precisely identify the 
components of anxiety sensitivity that are affected by 
repeated administration of anxiety sensitivity measures. 
Fear of respiratory symptoms. A 4_3 repeated 
measures ANOVA was computed on ASI-R fear of 
respiratory symptoms subscale scores. Results indicated 
a significant main effect for the assessment 
session on the fear of respiratory symptoms subscale, 
F(2, 332)568.50, Po.001, Zp 2 50.29, with higher 
scores at baseline (M515.46, SD59.14) than at post 
(M511.22, SD58.30) and follow-up (M510.51, 
SD58.40). Post hoc analyses indicated that the 
decrease from baseline to post was significant, as was 
the decrease from baseline to follow-up. However, the 
change in scores from post to follow-up did not attain 
significance. A significant group by time interaction 
effect was also noted, F(6, 332)52.35, P5.03, 
Zp 2 50.04. Follow-up analyses indicated that there 
was a differential change among the groups in fear of 
respiratory symptoms from baseline to post, F(3, 
169)53.51, P5.02, Zp 2 50.29. Specifically, the no 
interview group (M51.62, SD55.66) reported significantly 
less change in fear of respiratory symptoms 
than the SCID-A plus psychoeducation group 
(M55.26, SD56.18), and marginally less change than 
the SCID-A (M54.79, SD55.73) and SCID-P 
(M55.02, SD55.65). No group differences were 
 
noted with regard to change from baseline to followup 
or post to follow-up. 
 
Fear of publicly observable anxiety reactions. A 
4_3 mixed model ANOVA of the fear of publicly 
observable anxiety reactions subscale also revealed a 
significant main effect for the assessment session, F(2, 
332)520.29, Po.001, Zp 2 50.11. On average, participant 
scores significantly decreased from baseline, 
(M511.96, SD56.40) to post (M510.67, 
SD57.06) and follow-up (M510.39, SD57.36). 
However, no main effect for group or interaction 
effect was noted. Thus, all groups reported comparable 
decreases in fears of publicly observable anxiety 
reactions. 
 
Fear of cardiovascular symptoms. A 4_3 mixed 
model ANOVA of the fear of cardiovascular symptoms 
subscale indicated a significant main effect for the 
assessment session, F(2, 332)54.43, P5.01, Zp 2 50.03. 
Thus, participants reported a relatively small, though 
statistically significant, decline in scores from baseline 
(M55.28, SD55.76) to post (M54.57, SD55.34) 
and follow-up (M54.72, SD55.55). However, no 
main effect of group or interaction effect was indicated, 
suggesting that fears of cardiovascular symptoms 
decreased regardless of condition. 
 
Fear of cognitive dyscontrol. A 4_3 mixed 
model ANOVA applied to ASI-R fear of cognitive 
dyscontrol subscale scores did not indicate any main or 
interaction effects. Thus, scores on the cognitive 
dyscontrol domain seem to be relatively stable in 
comparison with the other ASI-R subscales. 
ROSENBERG SELF-ESTEEM SCALE 
In an attempt to determine whether the observed 
declines in ASI-R scores were the result of test 
reactivity or a general improvement in mood, a 4_2 
repeated measures ANOVA was also computed using 
RSES scores as the dependent measure. No significant 
main effect for time was noted, F(1, 166)50.32, 
P5.58, Zp 2 50.002, indicating that mean RSES scores 
did not change between baseline (M522.74, 
SD55.00) and follow-up (M522.88, SD54.92), 
and no group by time interaction was found (P4.20). 
Thus, overall mean self-esteem scores across the 
conditions remained stable between baseline and 
follow-up. The relative change in RSES scores was 
also not significant among the groups, F(3, 169)51.44, 
P4.20. 
 
DISCUSSION 
 
Several recent studies have noted significant reductions 
in anxiety sensitivity scores in both treatment and 
control conditions, particularly in the presence of a 
structured diagnostic interview, raising concerns about 
the use of self-report anxiety sensitivity measures in 
prospective research. This study sought to further 
explore this issue by evaluating the stability of anxiety 
sensitivity scores under multiple conditions. Overall, 
results were consistent with those of previous reports in 
suggesting that anxiety sensitivity scores tend to decline 
over time. Specifically, scores on a measure of anxiety 
sensitivity (ASI-R) significantly decreased from baseline 
to post, regardless of condition, and lower scores 
were maintained at 2-week follow-up. Thus, regardless 
of condition, participants, on average, reported significantly 
less fear of anxiety sensations at the second 
test administration even if they had not received an 
interview. 
 
Previous work using individuals with high levels of 
anxiety sensitivity had indicated that decreases in ASI 
scores may be due to the administration of a structured 
interview containing information about anxiety.[9] The 
rationale behind this idea is that structured interviews 
may provide indirect normalizing information about 
anxiety symptoms, which may in turn reduce fears of 
anxiety-related sensations. We tested this notion 
experimentally by providing either indirect information 
(a structured anxiety-related clinical interview), clear 
and unequivocal direct information (interview plus 
education), or no information. A comparison of the 
absolute and relative change in general anxiety 
sensitivity scores among the indirect information and 
no interview groups revealed no differences, suggesting 
that brief normalizing information directly resulting 
from the administration of a structured diagnostic 
interview for anxiety disorders cannot account for the 
systematic declines in overall anxiety sensitivity scores. 
However, the administration of an anxiety-related 
diagnostic interview in combination with the provision 
of direct information regarding the physiological 
experience of anxiety did appear to convey some 
benefits. For example, although not statistically significant, 
a comparison of group means revealed that the 
direct information group reported a slightly greater 
decrease in overall anxiety sensitivity scores from 
baseline to post in comparison with the no interview/ 
no information group. Furthermore, an analysis of 
scores on the subcomponents of anxiety sensitivity 
revealed that the provision of direct information did 
result in significantly greater decreases in fears of 
respiratory symptoms, from baseline to post, in 
comparison with the no interview condition. Direct 
information also produced a greater, though marginally 
significant, decline in self-reported fear of respiratory 
symptoms from baseline to post in comparison with 
indirect information as well. However, it should be 
noted that these differences were not maintained at 2- 
week follow-up, and no differences were noted between 
the groups on any of the other subscales. Furthermore, 
the SCID-A plus education group spent the most time 
in the laboratory of all the groups, thus raising 
questions regarding whether the benefits reported by 
the SCID-A plus education group were due to the 
educational component or were an artifact of time 
spent in the laboratory. Thus, although the provision of 
direct information regarding the dangerousness of 
anxiety symptoms may convey some additional short-term 
benefits with regard to fear of respiratory 
symptoms, these benefits do not appear to generalize 
to the other facets of anxiety sensitivity, and additional 
research will be necessary to clarify the source of these 
benefits. 
 
Noting that previous studies did not investigate the 
relative latency of the observed anxiety sensitivity 
reductions, this study sought to address this issue by 
assessing anxiety sensitivity scores at baseline, immediately 
after the participant’s completion of their 
relative condition, and again at a 2-week follow-up 
appointment. Results indicated that the significant 
reductions in ASI-R scores occurred between baseline 
and post, a period of approximately 5–7 min on average 
for the SCID-A, SCID-P, and control conditions, and 
25–30 min for the SCID-A plus psychoeducation 
group. In other words, participants who spent 5 min 
alone in a room that contained only chairs and a table 
reported significant reductions in anxiety sensitivity 
comparable to those of individuals who spent 30 min 
completing a diagnostic interview and receiving education 
regarding typical psychophysiological responses 
that occur during anxiety responses. Thus, the spontaneous 
improvements in self-report anxiety sensitivity 
appear to occur relatively quickly and are maintained 
for at least several weeks. It will be beneficial for future 
research to examine the relative duration of these 
changes in anxiety sensitivity scores, as the time frame 
under which they occur and are maintained could help 
to inform the design of anxiety sensitivity research, 
 
particularly those studies involving a longitudinal 
assessment of the construct. 
 
Several other potential explanations exist for the 
decreases in anxiety sensitivity that have now been 
noted across several studies by independent research 
groups. For example, it is possible that the mere 
completion of anxiety sensitivity questionnaires has a 
systematic impact on self-reported fears of anxiety 
sensations. It is possible that exposure to questions 
regarding fears of anxiety sensations leads to increased 
attention, monitoring, and/or cognitive processing of 
these fears, which, in turn, may cause a mild, but 
statistically significant, decrease in anxiety sensitivity. 
This explanation would be consistent with research 
indicating that self-monitoring of various other forms 
of behavior, such as smoking [e.g.,][22] and binge 
eating,[23] can lead to a significant decline in the 
monitored behavior. Thus, the mere administration of 
anxiety sensitivity measures may have a mild effect on 
fears of anxiety sensations. We are currently in the 
process of experimentally evaluating this possibility and 
the potential dose–response effect of administering 
measures of anxiety sensitivity to individuals over 
various time frames. 
 
Alternatively, it is possible that heightened levels of 
arousal or anxiety experienced in anticipation of a novel 
laboratory situation lead to an artificial inflation of self-reported 
fears of anxiety sensations. However, as the 
individual habituates to the laboratory environment 
and requirements of the study, a reduction in overall 
arousal and anxiety levels may lead to lower levels of 
reported fears of anxiety. Although previous research 
has indicated significant associations between anticipatory 
anxiety and anxiety sensitivity scores [e.g.,],[24] 
relatively little is known regarding the influence of 
anticipatory anxiety on anxiety sensitivity scores. Thus, 
it may be beneficial for future research into the 
spontaneous decline in anxiety sensitivity scores to 
assess for anticipatory anxiety via self-report and 
physiological measures to determine whether changes 
in anticipatory anxiety are associated with concomitant 
changes in anxiety sensitivity. 
 
A third potential explanation for these findings is that 
statistical regression, test reactivity, or some other nonspecific 
effect of the experimental design led participants 
to respond to the questionnaires in a more 
positive manner at post and follow-up. In an attempt to 
reduce the impact of statistical regression in this study, 
participants were not pre-selected based on extreme 
scores. Rather, individuals representing the full range 
of anxiety sensitivity scores were included in this study, 
and baseline ASI-R scores were found to be comparable 
to other non-selected samples [e.g.,].[11] Furthermore, 
a direct comparison of individuals with high 
[ASI-R scores 41 SD) versus low (ASI-R scores o1 
SD) anxiety sensitivity revealed that both groups 
reported significant reductions in anxiety sensitivity, 
with the low anxiety sensitivity individuals demonstrating 
a greater decline in relative change scores. Thus, it 
is highly unlikely that the observed decreases in anxiety 
sensitivity scores are the result of selection biases or 
statistical regression. 
 
To determine whether the temporal instability in 
self-report anxiety sensitivity scores was merely reflective 
of a general reactivity to assessment instruments, a 
non-anxiety sensitivity measure was also administered 
to participants. Results indicated that participants’ 
scores on a measure of self-esteem, which is a related 
but conceptually distinct construct, did not evidence 
significant changes over time. Thus, the temporal 
instability in anxiety sensitivity scores does not appear 
to be part of a broad-based phenomenon; but rather is 
specific to verbal-report measures of anxiety sensitivity. 
Replication of the present findings with other selfreport 
measures of anxiety sensitivity [e.g., anxiety 
sensitivity profile],[25] along with an analysis of the 
stability of other anxiety sensitivity-related constructs 
(e.g., trait anxiety), would help to confirm that the 
often observed decrease in anxiety sensitivity scores is 
indeed specific to verbal-report measures of anxiety 
sensitivity. 
 
Although spontaneous declines in anxiety sensitivity 
scores have been noted in numerous studies and the 
results of this research suggest that this effect is a 
relatively robust phenomenon, we should keep in mind 
that these investigations have relied on a single mode of 
assessment (i.e., self-report ASI or ASI-R scores). 
Thus, whether these declines in verbal-report anxiety 
sensitivity scores are truly reflective of decreased fear of 
anxiety symptoms, or whether they are merely indicative 
of the temporal instability of anxiety sensitivity 
self-report measures, remains unknown. Additional 
research using alternative indicators of anxiety sensitivity 
(e.g., physiological responses to biological 
challenge procedures) may prove useful in determining 
the extent to which spontaneous reductions in verbal report 
anxiety sensitivity scores are associated with 
concurrent changes in the physiological and behavioral 
manifestations of anxiety sensitivity. 
Regardless of the source, the now well-replicated 
phenomenon of declining anxiety sensitivity scores 
provides an interesting cautionary tale for clinical 
researchers. Specifically, a systematic decline in anxiety 
sensitivity scores has critical implications for the design 
and interpretation of longitudinal research. For example, 
this research highlights the importance of demonstrating 
that treatments designed to impact anxiety 
sensitivity, at a minimum, produce significantly greater 
reductions in anxiety sensitivity than control conditions 
assessed over the same time frame. Although numerous 
anxiety sensitivity interventions have been investigated, 
ranging from physical exercise[26] to cognitive-behavioral 
therapy [e.g.,],[27] many of the efficacy studies 
supporting these interventions either have not included 
an appropriate control condition [e.g.,],[27,28] or have 
not demonstrated the intervention to be significantly 
more effective in reducing anxiety sensitivity than 
control [e.g.,].[7] In addition to ensuring the use of 
adequate control conditions, researchers should consider 
including multiple baseline measurements of 
anxiety sensitivity in their prospective research designs. 
The results of this study suggest that the decline in 
anxiety sensitivity scores among ostensible control 
conditions occurs relatively early (i.e., within approximately 
5–30 min of completing the anxiety sensitivity 
measure the first time), and then remains relatively 
stable. Thus, multiple baseline measurements may 
provide researchers with a way to control for the 
‘‘natural’’ decline in anxiety sensitivity scores that has 
now been observed across multiple studies and various 
research designs. 
 
Perhaps most importantly, these findings have 
important implications for research beyond the anxiety 
sensitivity field. Psychometric studies of rating scales 
usually report temporal stability using simple bivariate 
correlations conducted on two administrations of an 
instrument. Results of this study, in which we found 
good test–retest correlations but also significant 
changes in means, suggest that a fuller picture of an 
instrument’s psychometric characteristics requires a 
comparison of means across administrations. Although 
not currently a standard practice, behavioral scientists 
should be encouraged to include this basic information 
when reporting the temporal properties of an instrument. 
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